Trials / Completed
CompletedNCT05253430
D1 vs D2 Lymphadenectomy in Gastric Cancer
Prognostic Implications of D1 vs D2 Lymphadenectomy in Gastric Cancer: a Propensity Score Matched Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 357 (actual)
- Sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a retrospective study with a propensity score-matched analysis in order to balance differences between patients with D1 and D2 lymphadenectomy for gastric cancer.The main aim is to analyse differences in the postoperative and oncological outcomes of patients with gastric cancer (GC) who underwent D1 and D2 gastrectomy.
Detailed description
In this propensity score-matched analysis of 128 patients, D2 lymphadenectomy improved long-term outcomes compared with D1 in patients with curative intent surgery for gastric cancer except for the group of patients older than 75 years and with early tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Lymphadenectomy type | D1 vs D2 lymph node dissection |
Timeline
- Start date
- 1990-04-01
- Primary completion
- 2019-10-01
- Completion
- 2021-02-01
- First posted
- 2022-02-23
- Last updated
- 2022-02-23
Source: ClinicalTrials.gov record NCT05253430. Inclusion in this directory is not an endorsement.